This inventor holds 1 USPTO granted patent. Top assignee: Hyundai Pharm Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kyu-Hwan Lee: Innovator in GLP-1 Receptor Agonist Development
Introduction
Kyu-Hwan Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GLP-1 receptors. His work is essential for advancing treatments for diseases associated with GLP-1 activity.
Latest Patents
Kyu-Hwan Lee holds a patent for a GLP-1 receptor agonist. The invention relates to a compound represented by Formula 1, wherein A, B, L, X, and R are as described in the patent documentation, or a pharmaceutically acceptable salt thereof. This compound serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of diseases associated with GLP-1 activity. He has 1 patent to his name.
Career Highlights
Kyu-Hwan Lee is currently employed at Hyundai Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work at Hyundai Pharm has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Some of his notable coworkers include Han Kyu Lee and Jeong-Un Hwang. Their collaborative efforts contribute to the innovative environment at Hyundai Pharm.
Conclusion
Kyu-Hwan Lee's contributions to the field of GLP-1 receptor agonists highlight his role as an important inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile